Highest development stage: Approved

Development status: Active

Gram-positive activity

Gram-negative activity

Propensity to select resistant bacteria

Mechanism of Action/Target pathogen: Acute bacterial skin and skin structure infections; other potential indications: community-acquired bacterial pneumonia and complicated urinary tract infections